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Ovarian tumorsAbstract Purpose: To highlight the role of ADC value measurement in differentiating benign
from malignant ovarian tumors.
Materials and methods: Twenty patients with ovarian neoplasms underwent conventional MRI
including ADC value calculation before surgery. Retrospective analysis of the pathological speci-
men with lesion morphology, signal characteristics, enhancement criteria and correlation with the
appearance at DWI followed by ADC value measurement were obtained.
Results: Twenty patients with ovarian mass lesions were included. They were divided into purely
solid, purely cystic and complex solid/cystic lesions. All solid malignant lesions showed diffusion
restriction as well as the wall and septations of most malignant cystic lesion however, except one
case. All benign lesions did not display diffusion restriction in DWI. The best cut off value of
ADC to discriminate between benign and malignant lesions was 0.9 with speciﬁcity of 100%, sen-
sitivity of 88.9%, NPV of 75%, PPV of 100% and accuracy of 91.7%.
Conclusion: Addition of ADC value measurement to conventional MRI increases its speciﬁcity
from 78.6% to 85.7% which could be useful in differentiating benign from malignant lesions.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Ovarian cancer is the seventh most common malignancy
among women worldwide representing 3.7% of all cases of
cancer in women and the second most common gynecological
malignancy after cancer cervix (1). It is a disease of post-men-
opausal women and sometimes prepubescent girls. Risk fac-
tors include age more than 50, positive family history,
infertility and previous cancer. Ovarian malignancy usually
discovered at late stage (stages III and IV) with ﬁve year
survival rate of 20%. Fortunately if the disease is discovered
998 K.A. Ahmad, A. Abdrabouearlier (stage I), the ﬁve year survival rate will increases to
90%. Recurrence of cancer ovary in spite of aggressive treat-
ment is common (2–4).
Most malignant ovarian tumors are primary (95%) usually
of epithelial origin (90%). The epithelial tumors are classiﬁed
into serous, mucinous, endometrioid, clear cell and undifferen-
tiated. The non-epithelial tumors include sex cord stromal tu-
mors and germ cell tumors (dysgerminoma, teratoma, yolk sac
and choriocarcinoma). Most primary tumors which metasta-
size to the ovary includes gastric and colorectal (which are also
called Krukenberg tumors), breast, pancreas and melanoma
(5).
Cancer ovary metastasizes by several ways. Direct exten-
sion to the adjacent structures occurs after breaching the ovar-
ian capsule. Intraperitoneal dissemination through
implantation on the peritoneal surface, lymphatic spread to
the para-aortic lymph nodes and hematogenous spread to dis-
tant organs are all known routes of metastasis (6,7).
Several tools are available for detecting ovarian cancer;
however there is no single reliable diagnostic method. Ultraso-
nography plays a pivotal role in detecting ovarian lesions and
differentiates solid, cystic and complex cystic lesions (1).
With its multiplanar capability, superior tissue contrast and
different sequences, MRI becomes a crucial method of investi-
gation of ovarian lesions. MRI has high sensitivity (97%) and
speciﬁcity (84%) in characterizing malignant lesions and solves
the problem of indeterminate lesion on Ultrasonography (1).
Conventional MR sequences include T1, T2 and fat sup-
pressed images which provides anatomical and morphological
criteria of the lesion. Lesions with high signal on T1 (fat or
blood) and low signal in T2 (ﬁbrous tissue) are likely to be be-
nign (8). On the other hand, solid lesions with necrosis, cyst
with irregular wall or septum or presence of solid and cystic
component within the lesion are more likely to be malignant
(9). Administration of contrast agent e.g. Gd-DTPA with the
use of fat suppression can differentiate between the enhanced
solid component and non-enhanced debris and blood clots (1).
Diffusion weighted (DWI) MR imaging is an in vivo func-
tional method of investigation of various pathological condi-
tions (10).
It can be obtained by ultrafast spin-echo echoplanar T2 WI
with parallel imaging. As a modiﬁcation of T2 sequence, DWI
requires application of two diffusion sensitive gradients to the
classic spin echo sequence (paired grandients). One of them is
the dephasing gradient applied just before the 180 rephrasing
pulse and the other gradient applied after the 180 rephrasing
pulse. Both gradients should cancel each other and the tissue
with restricted diffusion will be fully rephrased and hence pre-
serve its T2 signal while the tissue with free diffusion, the water
molecules move signiﬁcantly between the two gradients and
would not be fully rephrased which results in loss of its T2 sig-
nal intensity (11–13).
Apparent diffusion coefﬁcient (ADC) is a quantitative deriv-
ative of DWI that can be expressed as a map or calculated as a
value. Multiple b-values should be obtained to reduce the error
in ADC calculation and improve tissue characterization (14).
Kwee et al. observed that inter- and intraobserver variation
of ADC measurements may not always be sufﬁcient to dis-
criminate malignant from nonmalignant lymph nodes. Fur-
thermore, ADC values tend to vary if different scanparameters or methods of measurement are applied, which
may limit reproducibility and comparability of ADC values
between centers (15).
The aim of the work is to highlight the role of ADC value
measurement in differentiating benign from malignant ovarian
tumors (Figs. 1–3).
2. Subjects and methods
2.1. Patients
The study was conducted in university hospital from January
2013 to September 2013. Twenty patients with ovarian tumors
were included. Their age ranged from 17 to 71 years (mean age
40.5 ± 13.6). Their symptomatology ranged from abdominal
enlargement, non-speciﬁc pelvic pain and loss of weight. All
patients were subjected to full history taken and clinical exam-
ination. Informed consents were obtained from all study par-
ticipants. Abdominal and Transvaginal Ultrasonographic
examination with Doppler study were performed to all patients
to exclude normal individuals, patients with functional cysts
and to select cases for MRI referral. All patients underwent
surgical excision of the tumor and histopathology.
2.2. MR Protocol and Parameters
All studies were performed using a 1.5T MR imaging unit
(Achiva, Philips medical system, Best, the Netherlands). All pa-
tients were imaged in supine position using a pelvic phased ar-
ray coil. Conventional pelvic MRI was performed followed by
DWI sequence. Conventional T2 axial, sagittal and coronal
were obtained with TR range/TE range: 3000–5000/90–100
and FOV (288 · 350 mm, 290 · 290 mm and 300 · 300 mm
respectively), T2 Axial SPAIR, T1 axial with TR/TE: 500/10
and FOV 260 · 216 mm. Fat suppressed T1 axial and coronal
post contrast images were obtained after injection of IV con-
trast (gadoterate meglumine (Dotarem, Guerbet) 0.1 ml/kg)
with TR range/TE range: 420–500/10 and FOV 260 · 216 mm
and 280 · 280 mm, respectively. DW axial images were ob-
tained with b-values of 0, 1000 and 1500 s/mm2, TR/TE was
5000/77, FOV of 240 · 240 mm, matrix size 124 · 100 and slice
thickness was 6 mm with 1 mm slice gap. Axial T2WI and DWI
of the abdomen were obtained to verify hepatic and peritoneal
mets in ovarian malignancy.
2.3. Image analysis
Two radiologists with at least 6 years of experience in MRI
served as study coordinators. They determined the lesions
and correlated the ﬁndings with the pathological specimens
after surgery. First, the conventional MR images were ana-
lyzed to detect the location, morphology, signal intensity and
post enhancement criteria of the lesion. Second, DWI and
ADC map were compared with the conventional MR ﬁndings.
High signal in T1 was considered due to blood or fat. Persis-
tence of high signal in fat suppressed images conﬁrmed its
bloody nature. Lesions with high signal on T2, high signal
on DWI and low signal on ADC were considered restricted dif-
fusion. Lesions with high signal on T2, DWI and ADC map
Fig. 1 Axial images of the pelvis, (a) T2, (b) Post contrast T1 fat suppressed image, (c) DWI (b-value 1000 s/mm2) and (d) ADC map. A
right ovarian solid lesion with central breaking down is noted. The solid component displays intermediate signal in T2, avid enhancement
in post contrast sequence, bright signal in DWI and low signal in ADC map denoting diffusion restriction. The calculated ADC value of
the solid component was 0.8 · 103 mm2/s and diagnosis of mucinous cystadenocarcinoma was made on pathology.
Fig. 2 Large bilateral ovarian complex solid/cystic lesions. The solid component displays avid enhancement in axial (a) and coronal (b)
post contrast fat suppressed T1 WIs. It exhibits bright signal in DWI (b value 1000 s/mm2) (c) and low signal in ADC map (d). The cystic
component shows facilitated diffusion displaying low signal in DWI and bright signal in ADC map. ADC value of the solid component
was 0.74 · 103 mm2/s and of the cystic component was 2.2 · 103 mm2/s. Pathological specimen revealed mucinous cystadenocarcinoma.
The signiﬁcance of added ADC value to conventional MR imaging 999were attributed to T2 shine through effect and not true diffu-
sion restriction. Lesions with low signal in DWI and high sig-
nal in ADC were considered facilitated diffusion.Quantitative analysis of the lesions was obtained via plot-
ting a region of interest (ROI) on expected location of the solid
component of the lesion on ADC map and measuring its ADC
Fig. 3 Axial T1WI (A), axial T2WI (B) and post contrast T1 with fat suppression (D) display mixed solid/cystic lesion with T2 bright
signal of the cystic component, low signal of the solid portion and mild enhancement of its wall and septa on post contrast scan. The lesion
displays bright signal on ADC (C), which favors benign nature of the lesion. ADC value was 2.4 · 103 mm2/s. Histopathology revealed
atypical mature cystic teratoma.
Table 1 Comparison between mri and dwi results.
MRI results (%) DWI results (%)
Sensitivity 100 83.3
Speciﬁcity 78.6 85.7
PPV 62.5 71.4
NPV 91.7 92.3
Accuracy 80 85
1000 K.A. Ahmad, A. Abdrabouvalue. The high ADC value was the more diffusion that oc-
curred in this ROI and vice versa.
3. Results
Ten patients had benign lesions and ten patients had malignant
tumors. The benign tumors included 4 serous cystadenoma, 3
mucinous cystadenoma, 2 mature cystic teratoma and 1 ovar-
ian ﬁbroma. The malignant tumors included 4 serous cystade-
nocarcinoma, 3 mucinous cystadenocarcinoma, 2 metastatic
deposits and 1 granulosa cell tumor. The benign lesions ranged
in size from 4.2 to 16 cm (mean size 9.3 cm) and the malignant
lesion ranged in size from 4 to 19 cm (mean size 11.4 cm).
Ten cases of the study were malignant. They were classiﬁed
into complex solid/cystic (7 cases), cystic (2 cases) and purely
solid (1 case). Two cases of the complex lesions were cysts with
intramural nodule >1 cm, one case was solid with cystic
degeneration and the rest were mixed solid and cystic. Four
cases showed moderate ascites and two were associated with
signiﬁcant pelvic lymphadenopathies. The enlarged internal
iliac lymph nodes display diffusion restriction yet the limited
number of cases with enlarged lymph nodes (2/20) has no sta-
tistical signiﬁcance could be addressed in our study. All solid
components of this group showed diffusion restriction on
DWI.
The two cystic lesions were multilocular cysts with thick
enhancing wall. The cyst contents did not express diffusion
restriction but their wall and septa did.The case with pure solid lesion (granulose cell tumor)
showed enhancement of post contrast study and diffusion
restriction on DWI.
The benign lesions were classiﬁed as 9 multilocular cystic
tumors and 1 purely solid lesion. The multilocular cystic le-
sions showed faint enhancement of their wall and septa with
no diffusion restriction on DWI. The solid lesion (ﬁbroma)
exhibited low signal in T1 and T2, faint enhancement in post
contrast study with no restricted diffusion on DWI.
Two cases (atypical mature cystic teratoma) were false po-
sitive by MRI and showed no diffusion restriction on DWI
which favor benignity. One case (serous cystadenocarcinoma)
was false negative by DWI which could be attributed to the
well differentiated nature of the lesion. The sensitivity, speciﬁc-
ity, NPV, PPV and accuracy were compared between conven-
tional MRI and DWI and expressed in Table 1.
So, addition of DWI to the conventional MR images did
not improve the sensitivity, but increased the speciﬁcity,
Table 2 Differences between ADC values in solid component in benign and malignant tumors.
Minimum Maximum Mean ± SD p-Value
ADC (·103 · mm2/s) in malignant tumors 0.13 0.90 0.56 (±0.26) 0.013
ADC (·103 · mm2/s) in benign tumors 1.1 1.55 1.18 (±0.24)
Table 3 Differences between ADC values in cystic component in benign and malignant lesions.
Minimum Maximum Mean ± SD p-Value
ADC (·103 · mm2/s) in malignant tumors 0.9 2.66 2.416 ( ± 0.73) 0.21
ADC (·103 · mm2/s) in benign tumors 1.8 2.9 2.54 ( ± 0.35)
The signiﬁcance of added ADC value to conventional MR imaging 1001PPV, NPV and accuracy from 78.6%, 62.5, 91.7% and 80% to
85.7%, 71.4%, 92.3% and 85%, respectively.
ADC values of solid and cystic components of benign and
malignant tumors were calculated and expressed in Tables 2
and 3, respectively which demonstrated a signiﬁcant statistical
difference between solid component malignant and benign tu-
mors (p-value of 0.013). As regards the cystic component there
was no signiﬁcant difference between benign and malignant le-
sions with p-value of 0.21 (p-value is considered signiﬁcant if
<0.05)
The best cut off value of ADC to discriminate between be-
nign and malignant lesions was 0.9 with speciﬁcity of 100%,
sensitivity of 88.9%, NPV of 75%, PPV of 100% and accuracy
of 91.7%.
4. Discussion
DWI is a new promising diagnostic tool that can be added to
conventional MRI to increase its speciﬁcity to better character-
ize and differentiate benign from malignant lesions (16).
In 2009, Thomassin-Naggara et al. evaluated the contribu-
tion of DWI in conjunction with morphological criteria to
characterize 77 complex adnexal masses (30 benign and 47
malignant). In their results, low signal intensity both on
DWI and T2-weighted images in the solid component of mixed
adnexal masses would predict benignity and could help in dif-
ferentiating benign from malignant lesion. This result matched
with our result (17).
A similar study carried out by Takeuchi and colleagues in
2010 on 49 ovarian tumors (39 malignant and 10 benign), all
solid malignant tumors showed diffusion restriction as well
as two of the benign tumors (thecomas) which was attributed
to their highly cellular content. He concluded that the presence
of low signal in DWI may suggest benign nature and it was dif-
ﬁcult to differentiate between benign and malignant tumors on
the basis of DWI alone (18). Again our study suggested that
low signal in T2 and DWI favors benignity of the lesion.
Another study was carried out by Li and colleagues in 2011
on 127 patients with 131 pelvic masses, (46 benign and 85
malignant). The purpose of this study was to evaluate differ-
ences in ADC values for the solid component of benign and
malignant ovarian surface epithelial tumors to differentiate be-
nign from malignant ovarian tumors preoperatively. The mean
ADC value measured for the cystic component did not differ
signiﬁcantly between benign and malignant masses. Unlike
that measured for the solid component which signiﬁcantly dif-
fered between the benign and malignant lesions. Mean ADC
value for benign lesions was 1.69 · 103 ± 0.25 SD mm2/s,and for the malignant was 1.03 · 103 ± 0.22 SD mm2/s.
The lower ADC value associated with the malignant group
was found to be statistically signiﬁcant. Their results suggest
that an ADC value P1.25 · 103 mm2/s may be an optimal
cutoff value for differentiating benign and malignant ovarian
tumors.
While in our study, the mean ADC value for solid malig-
nant lesions was 0.56 · 103 ± 0.26 SD mm2/s, while that for
solid benign lesions was 1.18 · 103 ± 0.24 SD mm2/s with
p-value = 0.013 that was considered statistically signiﬁcant.
Also in their study, the sensitivity, speciﬁcity, PPV, NPV
and accuracy of conventional MR imaging increased from
91.8%, 78.3%, 88.6%, 83.7% and 87.0%, respectively to
96.5%, 89.1%, 94.3%, 93.2% and 93.1% after adding DWI
to the conventional MR. This was comparable to our study
as addition of DWI to conventional raised the speciﬁcity,
PPV, NPV and accuracy from 78.6%, 62.5, 91.7% and 80%
to 85.7%, 71.4%, 92.3% and 85% with no improvement for
the sensitivity (19).
In our study we could not predict a deﬁnite cutoff value
due to our small number of cases, but when regarding solid
lesion only the best ADC cut off value between malignant
and benign lesion is 0.947 · 103 mm2 /s, with sensitivity
of 88.9%, speciﬁcity of 100%, PPV of 100%, and NPV
of 75%.
In a more recent study in 2012, Zhang et al. studied 191 pa-
tients with 202 ovarian masses and measured the ADC values
of their solid components. The study included 74 benign and
128 malignant lesions. The ADC values between benign and
malignant lesions were statistically signiﬁcant with cut off
point of 1.2 · 103 mm2/s (20). These results matched our
study however our cut off value was 0.9 · 103 mm2/s.
The small number of population in our study provided a
signiﬁcant limitation.5. Conclusion
Addition of ADC value measurement to the conventional
MRI sequences increases the speciﬁcity and accuracy of MRI
to discriminate between benign and malignant lesions. It is
easy to perform with short scan time and simple to interpret
which is ﬁnally reﬂected on patient’s outcome and prognosis.
Conﬂict of interest
No conﬂict of interest.
No Funds, sponsorship or ﬁnancial support to be disclosed.
1002 K.A. Ahmad, A. AbdrabouReferences
(1) Mohaghegh P, Rockall AG. Imaging strategy for early ovarian
cancer: characterization of adnexal masses with conventional and
advanced imaging techniques. Radiographics 2012;32(6):1751–73.
(2) Hongju S, Shahid M, Jamal R, et al. Role of FDG PET/CT in
staging of recurrent ovarian cancer. RadioGraphics
2011;31:569–83.
(3) Hippisley-Cox J, Coupland C. Identifying women with suspected
ovarian cancer in primary care: derivation and validation of
algorithm. BMJ 2012;344:1–11.
(4) Chu C, Kim S, June C, et al. Immunotherapy opportunities in
ovarian cancer. Expert Rev Anticancer 2008;8:243–57.
(5) Mironov S, Akin O, Pandit-Taskar N, et al. Ovarian cancer.
Radiol Clin North Am 2007;45(1):149–66.
(6) Kapadia AS, Devi KU. Epithelial ovarian cancer. In: Basu P,
Singh A, Pandey A, editors. A practical approach to gynecologic
oncology. New Delhi: Jaypee Brothers; 2005. p. 153–71.
(7) Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2004. CA
Cancer J Clin 2004;53:5–26.
(8) Thomassin-Naggara I, Daraı¨ E, Cuenod CA, et al. Dynamic
contrast-enhanced magnetic resonance imaging: a useful tool for
characterizing ovarian epithelial tumors. J Magn Reson Imaging
2008;28(1):111–20.
(9) Sohaib SA, Sahdev A, Van Trappen P, et al. Characterization of
adnexal mass lesions on MR imaging. AJR Am J Roentgenol
2003;180(5):1297–304.
(10) Koh D, Collins D. Diffusion-weighted MRI in the body:
applications and challenges in oncology. AJR 2007;188:1622–35.
(11) Qayyum A. Diffusion-weighted imaging in the abdomen and
pelvis: concepts and applications. RadioGraphics
2009;29:1797–810.(12) Charlotte S, Andy C, Linda C, et al. Diffusion-weighted MR
imaging of female pelvic tumors: a pictorial review. RadioGraph-
ics 2009;29:759–78.
(13) Aliya Q. Diffusion-weighted imaging in the abdomen and pelvis:
concepts and applications. RadioGraphics 2009;29:1797–810.
(14) Malayeri AA, El Khouli RH, Zaheer A, et al. Principles and
applications of diffusion-weighted imaging in cancer detection
staging and treatment follow-up. Radiographics
2011;31(6):1773–91.
(15) Kwee TC, Takahara T, Luijten PR, Nievelstein RA. ADC
measurements of lymph nodes: inter- and intra-observer repro-
ducibility study and an overview of the literature. Eur J Radiol
2010;75(2):215–20.
(16) Fujii S, Kakite S, Nishihara K, et al. Diagnostic accuracy of
diffusion-weighted imaging in differentiating benign from malig-
nant ovarian lesions. J Magn Reson Imaging 2008;28:1149–56.
(17) Thomassin-Naggara I, Daraı¨ E, Cuenod CA, et al. Contribution
of diffusion-weighted MR imaging for predicting benignity of
complex adnexal masses. Eur Radiol 2009;19(6):1544–52.
(18) Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted
magnetic resonance imaging of ovarian tumors: differentiation of
benign and malignant solid components of ovarian masses. J
Comput Assist Tomogr 2010;34(2):173–6.
(19) Li W, Chu C, et al. Diffusion-weighted MRI: a useful technique
to discriminate benign versus malignant ovarian surface epithelial
tumors with solid and cystic components. Abdom Imaging
2012;37(5):897–903.
(20) Zhang P, Cui Y, Li W, et al. Diagnostic accuracy of diffusion-
weighted imaging with conventional MR imaging for differenti-
ating complex solid and cystic ovarian tumors at 1.5T. World J
Surg Oncol. 2012;10(1):237.
